Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation

Y Ofran; E Beohou; M Labopin; D Blaise; Jan Cornelissen; MR De Groot; G Socie; A Huynh; J Maertens; F Baron; M Mohty; A Nagler

doi:10.1111/bjh.15131

Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation

Y Ofran, E Beohou, M Labopin, D Blaise, Jan Cornelissen, MR De Groot, G Socie, A Huynh, J Maertens, F Baron, M Mohty, A Nagler

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	643-646
Number of pages	4
Journal	British Journal of Haematology
Volume	184
Issue number	4
DOIs	https://doi.org/10.1111/bjh.15131
Publication status	Published - 2019

Research programs

EMC MM-02-41-04

Access to Document

10.1111/bjh.15131

http://hdl.handle.net/1765/115215

Cite this

Ofran, Y., Beohou, E., Labopin, M., Blaise, D., Cornelissen, J., De Groot, MR., Socie, G., Huynh, A., Maertens, J., Baron, F., Mohty, M., & Nagler, A. (2019). Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. British Journal of Haematology, 184(4), 643-646. https://doi.org/10.1111/bjh.15131

Ofran, Y ; Beohou, E ; Labopin, M et al. / Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. In: British Journal of Haematology. 2019 ; Vol. 184, No. 4. pp. 643-646.

@article{f57c885e05a740f6a225862345f097f1,

title = "Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation",

author = "Y Ofran and E Beohou and M Labopin and D Blaise and Jan Cornelissen and {De Groot}, MR and G Socie and A Huynh and J Maertens and F Baron and M Mohty and A Nagler",

year = "2019",

doi = "10.1111/bjh.15131",

language = "Undefined/Unknown",

volume = "184",

pages = "643--646",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley & Sons Inc.",

number = "4",

}

Ofran, Y, Beohou, E, Labopin, M, Blaise, D, Cornelissen, J, De Groot, MR, Socie, G, Huynh, A, Maertens, J, Baron, F, Mohty, M & Nagler, A 2019, 'Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation', British Journal of Haematology, vol. 184, no. 4, pp. 643-646. https://doi.org/10.1111/bjh.15131

Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. / Ofran, Y; Beohou, E; Labopin, M et al.
In: British Journal of Haematology, Vol. 184, No. 4, 2019, p. 643-646.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation

AU - Ofran, Y

AU - Beohou, E

AU - Labopin, M

AU - Blaise, D

AU - Cornelissen, Jan

AU - De Groot, MR

AU - Socie, G

AU - Huynh, A

AU - Maertens, J

AU - Baron, F

AU - Mohty, M

AU - Nagler, A

PY - 2019

Y1 - 2019

U2 - 10.1111/bjh.15131

DO - 10.1111/bjh.15131

M3 - Article

C2 - 29468648

SN - 0007-1048

VL - 184

SP - 643

EP - 646

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 4

ER -

Ofran Y, Beohou E, Labopin M, Blaise D, Cornelissen J, De Groot MR et al. Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. British Journal of Haematology. 2019;184(4):643-646. doi: 10.1111/bjh.15131